from the better-insured-than-sorry dept.
Recognizing that some nanotech risks are not dissimilar to biotech risks, McManamey, Brettler & Associates — biotech insurance specialists — have issued a press release that makes clear their willingness to take on the insuring of nanotechnology-based businesses. While it's true that buying insurance doesn't by itself decrease risk, it does set up a financial incentive for all involved to identify and then work to reduce potential safety problems. Makes sense to us.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.